Showing 1 - 14 results of 14 for search 'Michael A. Pfaller', query time: 0.05s Refine Results
  1. 1
    Molecular Approaches to Diagnosing and Managing Infectious Diseases: Practicality and Costs

    Molecular Approaches to Diagnosing and Managing Infectious Diseases: Practicality and Costs by Michael A. Pfaller

    Published 2001-04-01
    Get full text
    Article
  2. 2
    Trends in the susceptibility of U.S. Acinetobacter baumannii-calcoaceticus species complex and Stenotrophomonas maltophilia isolates to minocycline, 2014–2021

    Trends in the susceptibility of U.S. Acinetobacter baumannii-calcoaceticus species complex and Stenotrophomonas maltophilia isolates to minocycline, 2014–2021 by Michael A. Pfaller, Dee Shortridge, Cecilia G. Carvalhaes, Mariana Castanheira

    Published 2023-12-01
    Get full text
    Article
  3. 3
    Update on the activity of delafloxacin against acute bacterial skin and skin-structure infection isolates from European hospitals (2014–2019)

    Update on the activity of delafloxacin against acute bacterial skin and skin-structure infection isolates from European hospitals (2014–2019) by Dee Shortridge, Michael A. Pfaller, Jennifer M. Streit, Robert K. Flamm

    Published 2020-12-01
    Get full text
    Article
  4. 4
    Surveillance of omadacycline activity tested against clinical isolates from the USA: report from the SENTRY Antimicrobial Surveillance Program, 2019

    Surveillance of omadacycline activity tested against clinical isolates from the USA: report from the SENTRY Antimicrobial Surveillance Program, 2019 by Michael A. Pfaller, Michael D. Huband, Dee Shortridge, Robert K. Flamm

    Published 2021-12-01
    Get full text
    Article
  5. 5
    Cefepime MIC as a Predictor of the Extended-Spectrum β-Lactamase Type in Klebsiella pneumoniae, Taiwan

    Cefepime MIC as a Predictor of the Extended-Spectrum β-Lactamase Type in Klebsiella pneumoniae, Taiwan by Wen Leong Yu, Michael A. Pfaller, Patricia L. Winokur, Ronald N. Jones

    Published 2002-05-01
    Get full text
    Article
  6. 6
    Antifungal Activity of Isavuconazole and Comparator Agents against Contemporaneous Mucorales Isolates from USA, Europe, and Asia-Pacific

    Antifungal Activity of Isavuconazole and Comparator Agents against Contemporaneous Mucorales Isolates from USA, Europe, and Asia-Pacific by Cecilia G. Carvalhaes, Paul R. Rhomberg, Michael D. Huband, Michael A. Pfaller, Mariana Castanheira

    Published 2023-02-01
    Get full text
    Article
  7. 7
    In Vitro Activity of Isavuconazole and Other Mould-Active Azoles against <i>Aspergillus fumigatus</i> with and without CYP51 Alterations

    In Vitro Activity of Isavuconazole and Other Mould-Active Azoles against <i>Aspergillus fumigatus</i> with and without CYP51 Alterations by Michael A. Pfaller, Cecilia G. Carvalhaes, Lalitagauri M. Deshpande, Paul R. Rhomberg, Mariana Castanheira

    Published 2023-05-01
    Get full text
    Article
  8. 8
    Ceftolozane-tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing healthcare-associated infections in Latin America: report from an antimicrobial surveillance program (2013–2015)

    Ceftolozane-tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing healthcare-associated infections in Latin America: report from an antim... by Michael A. Pfaller, Dee Shortridge, Helio S. Sader, Ana Gales, Mariana Castanheira, Robert K. Flamm

    Published 2017-11-01
    Get full text
    Article
  9. 9
    Azole resistance in Candida glabrata clinical isolates from global surveillance is associated with efflux overexpression

    Azole resistance in Candida glabrata clinical isolates from global surveillance is associated with efflux overexpression by Mariana Castanheira, Lalitagauri M. Deshpande, Andrew P. Davis, Cecilia G. Carvalhaes, Michael A. Pfaller

    Published 2022-06-01
    Get full text
    Article
  10. 10
    Antimicrobial activity of manogepix, a first-in-class antifungal, and comparator agents tested against contemporary invasive fungal isolates from an international surveillance programme (2018–2019)

    Antimicrobial activity of manogepix, a first-in-class antifungal, and comparator agents tested against contemporary invasive fungal isolates from an international surveillance prog... by Michael A. Pfaller, Michael D. Huband, Robert K. Flamm, Paul A. Bien, Mariana Castanheira

    Published 2021-09-01
    Get full text
    Article
  11. 11
    Pathogen frequency and resistance patterns in Brazilian hospitals: summary of results from three years of the SENTRY antimicrobial surveillance program

    Pathogen frequency and resistance patterns in Brazilian hospitals: summary of results from three years of the SENTRY antimicrobial surveillance program by Helio S. Sader, Ana C. Gales, Michael A. Pfaller, Rodrigo E. Mendes, Cássia Zoccoli, Afonso Barth, Ronald N. Jones

    Get full text
    Article
  12. 12
    Epidemiology and outcomes of invasive candidiasis due to non-albicans species of Candida in 2,496 patients: data from the Prospective Antifungal Therapy (PATH) registry 2004-2008.

    Epidemiology and outcomes of invasive candidiasis due to non-albicans species of Candida in 2,496 patients: data from the Prospective Antifungal Therapy (PATH) registry 2004-2008. by Michael A Pfaller, David R Andes, Daniel J Diekema, David L Horn, Annette C Reboli, Coleman Rotstein, Billy Franks, Nkechi E Azie

    Published 2014-01-01
    Get full text
    Article
  13. 13
    Multicenter Collaborative Study of the Interaction of Antifungal Combinations against <i>Candida</i> Spp. by Loewe Additivity and Bliss Independence-Based Response Surface Analysis

    Multicenter Collaborative Study of the Interaction of Antifungal Combinations against <i>Candida</i> Spp. by Loewe Additivity and Bliss Independence-Based Response Surface Analysis by Joseph Meletiadis, David R. Andes, Shawn R. Lockhart, Mahmoud A. Ghannoum, Cindy C. Knapp, Luis Ostrosky-Zeichner, Michael A. Pfaller, Vishnu Chaturvedi, Thomas J. Walsh

    Published 2022-09-01
    Get full text
    Article
  14. 14
    Methodologies for in vitro and in vivo evaluation of efficacy of antifungal and antibiofilm agents and surface coatings against fungal biofilms

    Methodologies for in vitro and in vivo evaluation of efficacy of antifungal and antibiofilm agents and surface coatings against fungal biofilms by Patrick Van Dijck, Jelmer Sjollema, Bruno P.A. Cammue, Katrien Lagrou, Judith Berman, Christophe d’Enfert, David R. Andes, Maiken C. Arendrup, Axel A. Brakhage, Richard Calderone, Emilia Cantón, Tom Coenye, Paul Cos, Leah E. Cowen, Mira Edgerton, Ana Espinel-Ingroff, Scott G. Filler, Mahmoud Ghannoum, Neil A.R. Gow, Hubertus Haas, Mary Ann Jabra-Rizk, Elizabeth M. Johnson, Shawn R. Lockhart, Jose L. Lopez-Ribot, Johan Maertens, Carol A. Munro, Jeniel E. Nett, Clarissa J. Nobile, Michael A. Pfaller, Gordon Ramage, Dominique Sanglard, Maurizio Sanguinetti, Isabel Spriet, Paul E. Verweij, Adilia Warris, Joost Wauters, Michael R. Yeaman, Sebastian A.J. Zaat, Karin Thevissen

    Published 2018-06-01
    Get full text
    Article

Search Tools: